Peptide T

DRUG4 trials

Sponsors

National Institute of Mental Health (NIMH), Advanced Peptides

Conditions

Cognition DisordersHIV InfectionsPeripheral Nervous System Disease

Phase 1

A Phase I Trial of Peptide T: Efficacy for the Neuropsychiatric Complications of Acquired Immunodeficiency Syndrome (AIDS).

CompletedNCT00000393

National Institute of Mental Health (NIMH)Cognition Disorders, HIV Infections

Start: 1988-01-31Updated: 2015-03-02

A Phase I Trial of Intranasal Peptide T: Safety, Toxicity, and Pharmacokinetics in Human Immunodeficiency Virus-1 (HIV-1) Infected Patients.

CompletedNCT00000391

National Institute of Mental Health (NIMH)HIV Infections

Start: 1988-01-31Updated: 2015-03-03

Phase 2

Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment.

CompletedNCT00000392

National Institute of Mental Health (NIMH)Cognition Disorders, HIV Infections

Start: 1990-01-31End: 1996-08-31Updated: 2017-02-28

Unknown Phase

Intranasal Peptide T in the Treatment of Painful Peripheral Neuropathy of AIDS

CompletedNCT00002083

Advanced PeptidesHIV Infections, Peripheral Nervous System Disease

Updated: 2005-06-24